Evidence map›Paper›PMID 42646507›Full record

ArticleMethods and protocols2026

Agarose-Based 3D Invasion Assay for Simultaneous Quantification of Tumor Cell Invasion and Extracellular Matrix Degradation.

Andreas R Thomsen, Pascaline Kouam-Daniel, Bettina Priesch-Grzeszkowiak, Anja Grillenberger, Sandra Kumbruch, Ali H Acikelli, Helmut Bühler, Christian Baues

Abstract read
In one paragraph

Article in Methods and protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andreas R ThomsenDepartment of Radiation Oncology, University of Freiburg, 79106 Freiburg, Germany.ORCID 0000-0002-0163-8677
Pascaline Kouam-DanielInstitute for Molecular Oncology, Radio-Biology and Experimental Radiotherapy, Marien Hospital Herne, University Clinic of Ruhr-University Bochum, 44265 Herne, Germany.ORCID 0000-0003-4273-147X
Bettina Priesch-GrzeszkowiakInstitute for Molecular Oncology, Radio-Biology and Experimental Radiotherapy, Marien Hospital Herne, University Clinic of Ruhr-University Bochum, 44265 Herne, Germany.
Anja GrillenbergerInstitute for Molecular Oncology, Radio-Biology and Experimental Radiotherapy, Marien Hospital Herne, University Clinic of Ruhr-University Bochum, 44265 Herne, Germany.
Sandra KumbruchInstitute for Molecular Oncology, Radio-Biology and Experimental Radiotherapy, Marien Hospital Herne, University Clinic of Ruhr-University Bochum, 44265 Herne, Germany.
Ali H AcikelliDepartment of Haematology and Oncology, Institute of Molecular Oncology and Experimental Therapeutics, Marien Hospital Herne, University Clinic of Ruhr-University Bochum, 44265 Herne, Germany.ORCID 0000-0002-7575-4152
Helmut BühlerInstitute for Molecular Oncology, Radio-Biology and Experimental Radiotherapy, Marien Hospital Herne, University Clinic of Ruhr-University Bochum, 44265 Herne, Germany.ORCID 0000-0003-2094-8029
Christian BauesInstitute for Molecular Oncology, Radio-Biology and Experimental Radiotherapy, Marien Hospital Herne, University Clinic of Ruhr-University Bochum, 44265 Herne, Germany.ORCID 0000-0003-1733-6064

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor cell invasion is a critical step in local tumor progression, recurrence, and metastasis. Conventional two-dimensional migration assays and many existing three-dimensional invasion models often assess cell migration, invasion into the extracellular matrix and matrix degradation as separate endpoints, although these processes are tightly coupled in vivo. Therefore, robust and reproducible in vitro models are needed to investigate tumor cell invasion under defined extracellular matrix conditions. We developed an agarose-based three-dimensional invasion assay, termed the Freiburg 3D invasion assay, for the simultaneous analysis of tumor cell migration, invasion, and extracellular matrix degradation. The system consists of a 2.8% agarose matrix containing defined microcavities connected by a common loading channel. Tumor cells are seeded into these microcavities, where they form compact cell aggregates. The cavities are subsequently filled with collagen type I or extracellular matrix gel. After polymerization, the matrix-containing agarose strips are transferred into parking pockets, cultured for several days, and monitored by microscopy. Invasion distance, single-cell migration, and ECM-cleared area are quantified from serial microscopic images using image analysis software. The system distinguished weakly invasive MCF7 breast cancer cells from highly invasive MDA-MB-231 cells. In addition, treatment with a protease inhibitor and irradiation reduced tumor cell invasion and extracellular matrix remodeling, demonstrating the suitability of the assay for pharmacological and radiation-response studies. The Freiburg 3D invasion assay provides a practical and reproducible three-dimensional in vitro model for analyzing tumor cell invasion and protease-associated extracellular matrix degradation.

Indexed as

3D invasion assayagaroseextracellular matrixmatrix degradationtumor invasion

Identifiers

PMID42646507
PMCPMC13515452

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.